BSE filing, NSE: ELFORGE. Summary written from the filing by ALFA Finder's alert engine.
EL Forge Ltd: key numbers
- Share price
- ₹21.50
- Market cap
- ₹43.70 Cr
- Revenue (annual)
- ₹80.41 Cr
- Net profit (annual)
- ₹2.44 Cr
- P/E (TTM)
- 13.6×Sector 30.9×
- Promoter holding
- 40.78%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EL Forge Ltd
All →EL Forge Management Change
El Forge's Independent Director S. Balakrishnan ceased to hold office after completing his five-year term on 12 October 2026. The departure has no financial or operational impact on the company.
EL Forge Management Change
El Forge Limited appointed Mrs. Shubha Ganesh as a Non-Executive Independent Director for a five-year term, effective September 29, 2026.
EL Forge Annual General Meeting
El Forge Ltd announced results of its postal ballot, confirming the appointment and re-appointment of its Independent Directors. All resolutions were passed by majority vote.
EL Forge Annual General Meeting
EL Forge Limited issued a Postal Ballot notice for the re-appointment of Mrs. Shubha Ganesh and appointment of Mr. M.S. Sivakaminathan as Independent Directors.
EL Forge Management Change
EL Forge Limited announced the cessation of Shubha Ganesh as Independent Director effective July 29, 2026. M/s. VRKSJP & CO. was appointed as Internal Auditor for a three-year term.
- Execution
- 36 months
EL Forge Q1 FY27 Results: Net Profit ₹1.2 Cr, Up 200.0% YoY
EL Forge Ltd reported revenue from operations of ₹21.8 Cr (+5.8% YoY) and net profit of ₹1.2 Cr (+200.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.2 Cr · +200.0% YoY
Other other announcement announcements
All →Milky Mist Dairy Food Other Announcement
Milky Mist's board appointed B Chandra & Associates as Secretarial Auditors for FY 2026-27 to 2030-31. Shareholder approval is pending at the ensuing AGM.
- Execution
- FY 2026-27 to FY 2030-31 (five years)
Mahamaya Lifesciences Other Announcement
Mahamaya Lifesciences Ltd, an SME-platform listed company, confirms non-applicability of Corporate Governance under Regulation 27(2) for the quarter ended 30 September 2026. A Company Secretary certificate is enclosed.
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
OK Play India Other Announcement
OK Play India filed its quarterly shareholding pattern for the quarter ended September 2026. It shows category holdings only, with no transaction.
Spice Islands Industries Other Announcement
Spice Islands Industries filed a Reg 32 statement reporting no deviation in preferential issue fund utilization for Q3 FY27. The ₹8.70 Crore raise is fully deployed.
Setubandhan Infrastructure Other Announcement
RP informs exchanges that Setubandhan Infrastructure cannot file quarterly compliance documents due to depository fee non-payment. The company remains under CIRP with a pending NCLAT appeal.